PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.78
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
0.57
P/S less than half of CRN.AX's 2.40. Joel Greenblatt would verify if margins support this discount.
-8.07
Negative equity while CRN.AX shows P/B of 1.11. Joel Greenblatt would examine balance sheet repair potential.
69.67
P/FCF less than half of CRN.AX's 361.43. David Dodd would verify if cash flow quality justifies this discount.
6.59
P/OCF less than half of CRN.AX's 25.50. David Dodd would verify if operating efficiency justifies this discount.
-8.07
Negative fair value while CRN.AX shows ratio of 1.11. Joel Greenblatt would examine valuation model differences.
-31.95%
Both companies show losses. Martin Whitman would check for industry-wide issues.
1.44%
FCF yield exceeding 1.5x CRN.AX's 0.28%. David Dodd would verify if cash flow quality justifies this premium.